Literature DB >> 25755412

Hepatocellular carcinoma presenting as budd-Chiari syndrome.

Anil Arora1, Pankaj Tyagi1, Samarjit Singh Ghuman2, Praveen Sharma1, Hardik L Kotecha1, Ashish Kumar1.   

Abstract

Entities:  

Keywords:  BCS, Budd–Chiari syndrome; Budd–Chiari syndrome; CECT, contrast-enhanced computed tomography; HCC, hepatocellular carcinoma; IVC, inferior vena cava; cirrhosis; hepatocellular carcinoma

Year:  2012        PMID： 25755412      PMCID： PMC3940214          DOI： 10.1016/S0973-6883(12)60086-3

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  8 in total

1.  Budd-Chiari syndrome and hepatocellular carcinoma.

Authors:  Masayoshi Kage
Journal:  J Gastroenterol       Date:  2004-07       Impact factor: 7.527

2.  Hepatocellular carcinoma with presentation of budd-Chiari syndrome.

Authors:  Wei-Yu Kao; Hung-Hsu Hung; Hsueh-Chieh Lu; Han-Chieh Lin; Jaw-Ching Wu; Shou-Dong Lee; Chien-Wei Su
Journal:  J Chin Med Assoc       Date:  2010-02       Impact factor: 2.743

3.  Budd-Chiari syndrome secondary to hepatocellular carcinoma.

Authors:  Sara Boutachali; Lionel Arrivé
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-08-17       Impact factor: 2.947

4.  Transatrial stent placement for treatment of inferior vena cava obstruction secondary to extension of intracardiac tumor thrombus from hepatocellular carcinoma.

Authors:  Michael J Wallace
Journal:  J Vasc Interv Radiol       Date:  2003-10       Impact factor: 3.464

Review 5.  Budd-Chiari syndrome: illustrated review of current management.

Authors:  John D Horton; Francisco L San Miguel; Fernando Membreno; Francis Wright; Juan Paima; Preston Foster; Jorge A Ortiz
Journal:  Liver Int       Date:  2008-04       Impact factor: 5.828

6.  Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications.

Authors:  Bita Boozari; Matthias J Bahr; Stefan Kubicka; Juergen Klempnauer; Michael P Manns; Michael Gebel
Journal:  J Hepatol       Date:  2008-06-06       Impact factor: 25.083

7.  Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

Authors:  Marcus Alexander Wörns; Arndt Weinmann; Kerstin Pfingst; Carla Schulte-Sasse; Claudia-Martina Messow; Henning Schulze-Bergkamen; Andreas Teufel; Marcus Schuchmann; Stephan Kanzler; Christoph Düber; Gerd Otto; Peter Robert Galle
Journal:  J Clin Gastroenterol       Date:  2009 May-Jun       Impact factor: 3.062

8.  Rapidly progressing Budd-Chiari syndrome complicated by hepatocellular carcinoma.

Authors:  Jeong Won Jang; Seung Kew Yoon; Si Hyun Bae; Jong Young Choi; Kyu Won Chung; Hee Sik Sun
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.